Unicentric castleman’s disease of neck node in old age- rare presentation of a rare disease
Castleman’s disease is an uncommon lymphoproliferative disorder that may be unicentric or multicentric disease. We are reporting a case of 75 year old female presented with left level 3 cervical lymph node, whose final diagnosis was unicentric castleman’s disease. This presentation is uncommon because unicentric castleman’s disease is usually seen in younger adults and it usually affects lymph nodes in chest or abdomen. People with localized Castleman’s disease are usually cured by surgical removal of the affected lymph nodes.
Aslı Gul Akgul, Bedrettin Yildizeli, Mustafa Yuksel. Castleman’s Disease. Marmara Medical Journal. 2005; 18(2): 81-83.
Lin CY, Huang TC. Cervical posterior triangle castleman's disease in a child - case report & literature review. Chang Gung Med J. 2011 Jul-Aug;34(4):435-9.
Zawawi F, Varshney R, Haegert DG, Daniel SJ. Castleman's Disease: a rare finding in a pediatric neck. Int J Pediatr Otorhinolaryngol. 2014 Feb;78(2):370-2. doi: https://doi.org/10.1016/j.ijporl.2013.11.015. Epub 2013 Nov 25.
Renuka. S. Melkundi, K C Prasad, Roshan R Jalisatgi, Gautham Swami, Abhilasha Karunasagar. Journal of Clinical and Diagnostic Research. 2015 Apr; 9(4): MD03–MD04.
Marcelin AG, Aaron L, Mateus C, et al. Rituximab therapy for HIV-associated Castleman disease. Blood. 2003 Oct 15; 102(8): 2786-8. Epub 2003 Jul 3. DOI: https://doi.org/10.1182/blood-2003-03-0951.
Ghosh A, Pradhan S V, Talwar C P. Castleman’s disease - hyaline vascular type. Clinical, cytological and histological features with review of literature. Indian Journal of Pathology. 2010 Apr-Jun; 53(2): 244-7.
Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer. 1999 Feb 1;85(3):706-17.
van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fosså A, Simpson D, Capra M, Liu T, Hsieh RK, Goh YT, Zhu J, Cho SG, Ren H, Cavet J, Bandekar R, Rothman M, Puchalski TA, Reddy M, van de Velde H, Vermeulen J, Casper C. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014 Aug;15(9):966-74. doi: https://doi.org/10.1016/S1470-2045(14)70319-5. Epub 2014 Jul 17.